A recent mouse study documented the first biochemical pathway involved in the physical symptoms of nicotine withdrawal 🐭🔬 and found that a common Parkinson’s drug 💊 can block these symptoms.
Read Full Article
#NicotineWithdrawal #ParkinsonsResearch #BiochemicalPathways #HealthScience #AddictionRecovery
Read Full Article
#NicotineWithdrawal #ParkinsonsResearch #BiochemicalPathways #HealthScience #AddictionRecovery
CHEST Physician
Parkinson’s drug shows promise as treatment for nicotine addiction in mouse model - CHEST Physician
Tobacco cessation expert, Carolyn Dresler, MD, MPA, said new evidence of cross talk between different types of acetylcholinergic receptors could be an important step for future research to determine if, and at what doses, these results could be replicated…
🤮1